Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
Novel Diagnostic Approaches for the Diagnosis of Alzheimer's Disease: Technology Assessment and Clinical Effectiveness
Sponsor: Amsterdam UMC, location VUmc
A observational or N/A phase clinical study on Memory Disturbances and Neurodegenerative Diseases, this trial is completed. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 12 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
-
Mar 2022 — May 2022 [monthly]
Completed
-
Dec 2021 — Mar 2022 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Center for Translational Molecular Medicine
- Leiden University Medical Center
- Maastricht University Medical Center
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .